EAM
OSRH

Exos Asset Management’s OSR Health OSRH Stock Holding History

Exos Asset Management’s Portfolio OSRH Stock Details OSRH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-200,000
Closed -$2.15M – 99
2024
Q2 		$2.15M Hold
200,000
– – 2.47% 23
2024
Q1 		$2.13M Buy
+200,000
New +$2.12M 1.26% 49

Other funds holding OSRH

WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
QL
Quarry LP New York $1.2B AUM 47.63% 1-Year Est. Return

Exos Asset Management's OSRH Position: Q3 2024 in Review

Exos Asset Management sold out of OSR Health (OSRH) in Q3 2024, closing a stake of 200,000 shares — an estimated $2.15M sold.

Exos Asset Management first reported a position in OSRH in Q1 2024 and held it in 2 quarters. The position peaked at $2.15M in Q2 2024. 13 funds tracked by Wall St. Rank hold OSRH as of Q3 2024.

  • Exos Asset Management reported no remaining OSR Health position as of Q3 2024 after selling out during the quarter.
  • Exos Asset Management sold 200,000 OSR Health shares in Q3 2024, an estimated $2.15M.
  • Exos Asset Management first reported a position in OSR Health in Q1 2024 and held it in 2 quarters.
  • Exos Asset Management's OSR Health position peaked at $2.15M in Q2 2024.
  • 13 funds tracked by Wall St. Rank held OSR Health as of Q3 2024.

Based on Exos Asset Management's 13F filing for Q3 2024, filed 13 Nov 2024.